Panjang
HIIQ - breaking out 52w High
Breaking out
Channel S&R: yes, rising up trend.
MA S&R: above both 20 and 50, breaking out 52w high
>200ma: yes
Volume confirmation: yes
Candle Confirmation: yes
Stoch Divergence: no
Reg Trendline > 85: n/a
Short Float: 23%
Risk / Reward: 2:1
Zacks Rank: 3-Hold 3 Style Scores: D Value | A Growth | D Momentum | B VGM Industry Rank: Top 8%(21 out of 255) Industry: Insurance - Life Insurance
Also worth noting:
Health Insurance Innovations price target raised to $60 from $56 at B. Riley FBR B. Riley FBR analyst Randy Binner raised his price target for Health Insurance Innovations to $60 after hosting investor meetings with management. The company's revenue opportunities "are numerous" against a backdrop of continued mainstreaming of short-term and limited-benefit health plans that it distributes, Binner tells investors in a research note. He keeps a Buy rating on the shares.
Channel S&R: yes, rising up trend.
MA S&R: above both 20 and 50, breaking out 52w high
>200ma: yes
Volume confirmation: yes
Candle Confirmation: yes
Stoch Divergence: no
Reg Trendline > 85: n/a
Short Float: 23%
Risk / Reward: 2:1
Zacks Rank: 3-Hold 3 Style Scores: D Value | A Growth | D Momentum | B VGM Industry Rank: Top 8%(21 out of 255) Industry: Insurance - Life Insurance
Also worth noting:
Health Insurance Innovations price target raised to $60 from $56 at B. Riley FBR B. Riley FBR analyst Randy Binner raised his price target for Health Insurance Innovations to $60 after hosting investor meetings with management. The company's revenue opportunities "are numerous" against a backdrop of continued mainstreaming of short-term and limited-benefit health plans that it distributes, Binner tells investors in a research note. He keeps a Buy rating on the shares.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.